# A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma

> **NCT01171781** · PHASE2 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 110 (estimated)

## Conditions studied

- Nasophayngeal Carcinoma Between Stage II and IVb

## Interventions

- **DRUG:** cisplatin (3 weekly)
- **DRUG:** cisplatin (weekly)

## Key facts

- **NCT ID:** NCT01171781
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-11
- **Primary completion:** 2012-06
- **Final completion:** 2014-06
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2010-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171781, "A Randomized Phase II Study of Concurrent Chemoradiation With Every 3 Week of Cisplatin vs With Weekly Cisplatin in Locally Advanced Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01171781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*